Trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane
C20H32BNO3Si — CID 169306021
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane
Trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane (PubChem CID 169306021) has the molecular formula C20H32BNO3Si and a molecular weight of 373.38 g/mol. Its IUPAC name is trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane.
Molecular Properties
| Compound Name | Trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane |
|---|---|
| PubChem CID | 169306021 |
| Molecular Formula | C20H32BNO3Si |
| Molecular Weight | 373.38 g/mol |
| Exact Mass | 373.22 |
| IUPAC Name | trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indol-1-yl]methoxy]ethyl]silane |
| SMILES | CC1(C)OB(c2cccc3c2ccn3COCC[Si](C)(C)C)OC1(C)C |
| InChI | InChI=1S/C20H32BNO3Si/c1-19(2)20(3,4)25-21(24-19)17-9-8-10-18-16(17)11-12-22(18)15-23-13-14-26(5,6)7/h8-12H,13-15H2,1-7H3 |
| InChIKey | KQBFQLLEJNFRQO-UHFFFAOYSA-N |
| XLogP | 4.25 |
| TPSA | 32.62 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.38 |
| LogP ≤ 5 | 4.25 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169306021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.